Bruker Daltonics, an operating company of Bruker BioSciences Corporation
(NASDAQ: BRKR), is a leading developer and provider of innovative life science tools based on mass spectrometry. We design, manufacture and market a broad array of products intended to meet the rapidly growing needs of a diverse customer base, including pharmaceutical, biotechnology, proteomics and molecular diagnostics companies, academic institutions and government agencies.
Bruker Daltonics has diverse technology platforms that integrate MALDI-TOF, MALDI-TOF/TOF, (Q-q-) FTMS, ESI-Ion Trap, ESI-TOF, and ESI-Q-q-TOF mass spectrometry systems with automated sample processing systems and productivity-enhancing software for life science applications.
We are also a worldwide leader in supplying systems for substance detection and pathogen detection in security, defense and anti-terrorism. Field-hardened systems make use of advanced mass and ion mobility spectrometry as well as Fourier Transform infrared spectroscopy technologies.
Headquartered in the US, with major facilities in Germany (Bremen and Leipzig) and the US (Billerica, MA), as well as worldwide sales & service centers, the Bruker Daltonics corporation currently employs about 700 people.